Top Markets
Coin of the day
Beijing Biostar Pharms Co Ltd Beijing Biostar Pharms Co Ltd

Beijing Biostar Pharms Co Ltd

2563
Rangering i aksjer #21402
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing... Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
Aksjekurs
$0.44774181
Sist synkronisert: 2026-08-21
Markedsverdi
$108.23M
Endring (1 dag)
2.19%
Endring (1 år)
-61.12%
Land
CN
Handel Beijing Biostar Pharms Co Ltd (2563)

Kategori

P/S-forhold for Beijing Biostar Pharms Co Ltd (2563)
P/S-forhold per 2026 TTM: 0
Ifølge Beijing Biostar Pharms Co Ltd sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Beijing Biostar Pharms Co Ltd fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH